IMPACT HTA, WP7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2 (Multi-criteria evaluation framework), Results of the 1st Web-Delphi process to HTA stakeholders, organized into 6 separate parallel panels

From MaRDI portal
Dataset:6701597



DOI10.5281/zenodo.5256672Zenodo5256672MaRDI QIDQ6701597FDOQ6701597

Dataset published at Zenodo repository.

Carlos Bana e Costa, Aris Angelis, Panos Kanavos, Mónica Duarte Oliveira, Ana Lopes Vieira, Klára Dimitrovová

Publication date: 25 August 2021

Copyright license: Creative Commons Attribution 4.0 International



IMPACT HTA, WP7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2 (Multi-criteria evaluation framework), Results of the 1st Web-Delphi process to HTA stakeholders, organized into 6 separate parallel panels (one panel per stakeholder group, 2 rounds), about the views of stakeholders regarding This aspect should be considered in the evaluation of new medicines on a common basis (2019) For details on the Web-Delphi process, see: IMPACT HTA, Work Package 7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2, Deliverable 7.2 (Multi-criteria evaluation framework), Advancing knowledge and MCDA tools to assist HTA agencies in evaluating medicines on a common basis (2021) Oliveira, M.D. (IST), Panos Kanavos (LSE), Bana e Costa, C. (IST)







This page was built for dataset: IMPACT HTA, WP7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2 (Multi-criteria evaluation framework), Results of the 1st Web-Delphi process to HTA stakeholders, organized into 6 separate parallel panels